In summary, TLSs provide a structured setting for the recruitment, activation, and expansion of CD4+ and CD8+ T cells, thereby augmenting anti-tumor immune responses and improving the efficacy of immunotherapy in breast cancer. The gene discussed is CD8A; the disease is breast cancer.